"International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics" was held during August 5-7, 2013 at Holiday Inn Chicago – North shore, USA.

OMICS Group Personalized Medicine - 2013 has swirl up the scientific thoughts and proved its importance in the booming area of research with stash of results by following the sequence of the human genome. Examples of relevant areas for personalized medicine include genomics, proteomics, epigenomics, pharmacogenomics etc. 

The Conference has gathered support from American College of Lifestyle Medicine, Lifestyle Medicine 2013, and Bioadvance. The citing can be viewed at webpages of Media Partners. American College of Lifestyle Medicine, Sigma Aldrich has participated as an exhibitors in this conference.

All accepted abstracts have been indexed in OMICS Group Translational Medicine Journal as a special issue.

The highlights of the meeting were the eponymous Keynote lectures and Honorable Guests

Vincent Gallicchio - Clemson University, UNESCO, USA
Toshihisa Ishikawa – RIKEN Omics Science Centre, Japan
Dik C. Van Gent - Erasmus MC, Netherlands

Following organizations took part in Personalized Medicine- 2013

• Cambridge Isotope Laboratories Inc., USA
• Loyola University Medical Centre, USA
• Advanced Lifestyle medicine, USA
• Bioinformatics Institute, Singapore
• Avalon University, Netherlands
• Harvard Medical School, USA
• University of Aberdeen, UK
• Creighton University, USA
• Genentech, USA
• Rheonix Inc., USA
• Seegene Inc., Korea

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Editorial Board Members and OCM's for their gracious presence, support, and assistance towards the success of Personalized Medicine -2013

With the constant patronage of the Translational Medicine Journal, OMICS Group Conferences is glad to divulge our “2nd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics” during November 3-5, 2014 at Embassy Suites, Las Vegas, USA.

The move towards personalized medicine can be seen as an evolutionary rather than revolutionary process. Although some personalized medicine approaches have already been introduced into practice in Europe, we are at an early stage of its implementation. Significant paradigm shifts will need to take place in major fields of medical research and health care for this innovative area to be fully exploited.